vs
美国鹰（AEO）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
美国鹰的季度营收约是百利高的1.2倍（$1.4B vs $1.1B），美国鹰净利率更高（6.7% vs -127.8%，领先134.5%），美国鹰同比增速更快（5.7% vs -2.5%），百利高自由现金流更多（$148.6M vs $-2.5M），过去两年美国鹰的营收复合增速更高（2.3% vs 1.3%）
American Eagle Outfitters是美国知名服饰及配饰零售商，总部位于宾夕法尼亚州匹兹堡市南区工业园。品牌1977年由杰里·西尔弗曼与马克·西尔弗曼兄弟创立，最初为零售风险投资公司的子公司，旗下还运营西尔弗曼男装。1980年创始人向肖滕斯坦家族出售一半股权，1991年售罄剩余股份，目前旗下拥有Aerie、Unsubscribed等多个品牌。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
AEO vs PRGO — 直观对比
营收规模更大
AEO
是对方的1.2倍
$1.1B
营收增速更快
AEO
高出8.2%
-2.5%
净利率更高
AEO
高出134.5%
-127.8%
自由现金流更多
PRGO
多$151.1M
$-2.5M
两年增速更快
AEO
近两年复合增速
1.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.1B |
| 净利润 | $91.3M | $-1.4B |
| 毛利率 | 40.5% | 32.6% |
| 营业利润率 | 8.3% | -116.0% |
| 净利率 | 6.7% | -127.8% |
| 营收同比 | 5.7% | -2.5% |
| 净利润同比 | 14.2% | -3093.9% |
| 每股收益（稀释后） | $0.53 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEOPRGO
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.7B | $1.1B |
净利润AEOPRGO
| Q4 25 | $91.3M | $-1.4B | ||
| Q3 25 | $77.6M | $7.5M | ||
| Q2 25 | $-64.9M | $-8.4M | ||
| Q1 25 | — | $-6.4M | ||
| Q4 24 | $80.0M | $-44.4M | ||
| Q3 24 | $77.3M | $-21.0M | ||
| Q2 24 | $67.8M | $-108.4M | ||
| Q1 24 | $6.3M | $2.0M |
毛利率AEOPRGO
| Q4 25 | 40.5% | 32.6% | ||
| Q3 25 | 38.9% | 36.1% | ||
| Q2 25 | 29.6% | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | 40.9% | 33.9% | ||
| Q3 24 | 38.6% | 37.2% | ||
| Q2 24 | 40.6% | 37.0% | ||
| Q1 24 | 36.6% | 33.1% |
营业利润率AEOPRGO
| Q4 25 | 8.3% | -116.0% | ||
| Q3 25 | 8.0% | 7.0% | ||
| Q2 25 | -7.8% | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 8.2% | 10.0% | ||
| Q3 24 | 7.8% | 7.4% | ||
| Q2 24 | 6.8% | -2.5% | ||
| Q1 24 | 0.6% | -5.1% |
净利率AEOPRGO
| Q4 25 | 6.7% | -127.8% | ||
| Q3 25 | 6.0% | 0.7% | ||
| Q2 25 | -6.0% | -0.8% | ||
| Q1 25 | — | -0.6% | ||
| Q4 24 | 6.2% | -3.9% | ||
| Q3 24 | 6.0% | -1.9% | ||
| Q2 24 | 5.9% | -10.2% | ||
| Q1 24 | 0.4% | 0.2% |
每股收益（稀释后）AEOPRGO
| Q4 25 | $0.53 | $-10.23 | ||
| Q3 25 | $0.45 | $0.05 | ||
| Q2 25 | $-0.36 | $-0.06 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | $0.41 | $-0.32 | ||
| Q3 24 | $0.39 | $-0.15 | ||
| Q2 24 | $0.34 | $-0.79 | ||
| Q1 24 | $0.03 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $112.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.6B | $2.9B |
| 总资产 | $4.2B | $8.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEOPRGO
| Q4 25 | $112.8M | — | ||
| Q3 25 | $126.8M | $432.1M | ||
| Q2 25 | $87.9M | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | $160.2M | $558.8M | ||
| Q3 24 | $191.8M | $1.5B | ||
| Q2 24 | $300.5M | $542.8M | ||
| Q1 24 | $454.1M | $658.5M |
总债务AEOPRGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
股东权益AEOPRGO
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.5B | $4.4B | ||
| Q2 25 | $1.5B | $4.5B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | $1.7B | $4.3B | ||
| Q3 24 | $1.7B | $4.6B | ||
| Q2 24 | $1.8B | $4.5B | ||
| Q1 24 | $1.7B | $4.7B |
总资产AEOPRGO
| Q4 25 | $4.2B | $8.5B | ||
| Q3 25 | $4.1B | $10.1B | ||
| Q2 25 | $3.8B | $10.1B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | $3.7B | $9.6B | ||
| Q3 24 | $3.5B | $11.2B | ||
| Q2 24 | $3.6B | $10.4B | ||
| Q1 24 | $3.6B | $10.6B |
负债/权益比AEOPRGO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.1M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $148.6M |
| 自由现金流率自由现金流/营收 | -0.2% | 13.4% |
| 资本支出强度资本支出/营收 | 5.1% | 2.4% |
| 现金转化率经营现金流/净利润 | 0.74× | — |
| 过去12个月自由现金流最近4个季度 | $-169.8M | $145.1M |
8季度趋势，按日历期对齐
经营现金流AEOPRGO
| Q4 25 | $67.1M | $175.4M | ||
| Q3 25 | $27.8M | $51.7M | ||
| Q2 25 | $-54.7M | $75.9M | ||
| Q1 25 | — | $-64.5M | ||
| Q4 24 | $52.9M | $312.6M | ||
| Q3 24 | $78.3M | $42.2M | ||
| Q2 24 | $-38.1M | $9.5M | ||
| Q1 24 | $296.4M | $-1.4M |
自由现金流AEOPRGO
| Q4 25 | $-2.5M | $148.6M | ||
| Q3 25 | $-43.1M | $29.8M | ||
| Q2 25 | $-116.3M | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | $-7.8M | $274.9M | ||
| Q3 24 | $17.5M | $15.1M | ||
| Q2 24 | $-74.3M | $-18.9M | ||
| Q1 24 | $256.8M | $-26.5M |
自由现金流率AEOPRGO
| Q4 25 | -0.2% | 13.4% | ||
| Q3 25 | -3.4% | 2.9% | ||
| Q2 25 | -10.7% | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | -0.6% | 24.2% | ||
| Q3 24 | 1.4% | 1.4% | ||
| Q2 24 | -6.5% | -1.8% | ||
| Q1 24 | 15.3% | -2.4% |
资本支出强度AEOPRGO
| Q4 25 | 5.1% | 2.4% | ||
| Q3 25 | 5.5% | 2.1% | ||
| Q2 25 | 5.7% | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 4.7% | 3.3% | ||
| Q3 24 | 4.7% | 2.5% | ||
| Q2 24 | 3.2% | 2.7% | ||
| Q1 24 | 2.4% | 2.3% |
现金转化率AEOPRGO
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.36× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | -0.56× | — | ||
| Q1 24 | 46.93× | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEO
| American Eagle Brand | $800.4M | 59% |
| Aerie Brand | $429.1M | 31% |
| Other | $133.2M | 10% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
